{
    "clinical_study": {
        "@rank": "80437", 
        "acronym": "inSighT", 
        "arm_group": [
            {
                "arm_group_label": "Merlin.net", 
                "description": "Group 1 uses Merlin.net for remote monitoring, i.e. scheduled follow ups every 6 months in clinic, collection of ST Segment, ATP and Shock Therapy delivered alerts via Merlin.net."
            }, 
            {
                "arm_group_label": "Non Merlin.net", 
                "description": "Group 2 will not use Merlin.net, i.e. scheduled follow ups every 3 months in clinic for alert review during device interrogation.\nThe use of Merlin.net will be per physician's preference."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this investigation is to determine the prevalence of device-recorded ST\n      segment changes occurring before appropriate ICD therapies (ATP or Shock) and to define\n      their temporal relationship to ventricular arrhythmias."
        }, 
        "brief_title": "A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular Arrhythmias", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Arrhythmias, Cardiac", 
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patient is implanted with an SJM ICD with ST Monitoring and ShockGuard\u2122 features\n             (and remote care feature in case Merlin.net will be used)\n\n          -  The patient, in the opinion of the investigator, will not require ventricular pacing\n             for more than 20% of the time.\n\n          -  The patient, in the opinion of the investigator, has or is at high risk of CAD.\n\n          -  The patient is \u2265 18 years of age.\n\n          -  The patient is able to provide written Informed Consent prior to any investigational\n             related procedure.\n\n        Exclusion Criteria:\n\n          -  The patient has longstanding persistent AF/AFl or permanent AF/AFl\n\n          -  The patient has documented complete heart block.\n\n          -  The patient is known to have uncontrolled ventricular bigeminy or trigeminy (PVCs on\n             regular basis).\n\n          -  The patient has severe Left Ventricular Hypertrophy resulting in interventricular\n             conduction defect (IVCD).\n\n          -  The patient has intermittent bundle branch blocks (BBB).\n\n          -  The patient is unable to comply with the follow up schedule.\n\n          -  The patient is participating in another investigational device or drug investigation.\n\n          -  The patient is pregnant or is planning to become pregnant during the duration of the\n             investigation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patient is implanted with SJM ICD and has or is at high risk of CAD"
            }
        }, 
        "enrollment": {
            "#text": "470", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01685047", 
            "org_study_id": "CR-12-014-ID-HV"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Coronary Artery Disease", 
            "Ventricular Arrhythmias", 
            "ST Segment Changes"
        ], 
        "lastchanged_date": "January 30, 2014", 
        "location": {
            "contact": {
                "email": "j.sperzel@kerckhoff-klinik.de", 
                "last_name": "Johannes Sperzel, MD", 
                "phone": "+49 6032 996 2239"
            }, 
            "facility": {
                "address": {
                    "city": "Bad Nauheim", 
                    "country": "Germany", 
                    "zip": "D-61231"
                }, 
                "name": "Kerckhoff Klinik"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "2", 
        "official_title": "A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular Arrhythmias", 
        "overall_contact": {
            "email": "ktimmermans@sjm.com", 
            "last_name": "Karolien Timmermans", 
            "phone": "+3227746741"
        }, 
        "overall_contact_backup": {
            "email": "graux@sjm.com", 
            "last_name": "Guillaume Raux, PhD", 
            "phone": "+32 277 468 37"
        }, 
        "overall_official": {
            "affiliation": "Kerckhoff Klinik, Bad Nauheim Germany", 
            "last_name": "Johannes SPERZEL, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Ethics Committee", 
                "Canada: Ethics Review Committee", 
                "China: Ethics Committee", 
                "Finland: Ethics Committee", 
                "France: Committee for the Protection of Personnes", 
                "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
                "Germany: Ethics Commission", 
                "Hong Kong: Ethics Committee", 
                "India: Ethics Committee", 
                "Italy: Ethics Committee", 
                "Japan: Institutional Review Board", 
                "Netherlands: Medical Ethics Review Committee (METC)", 
                "United Kingdom: Department of Health", 
                "United Kingdom: Research Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Among patients with an appropriate ICD therapy (shock or ATP) for ventricular tachycardia or fibrillation, determine the proportion of patients who have characterized ST segment changes from baseline prior to the therapy.", 
            "safety_issue": "No", 
            "time_frame": "End of follow up period"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01685047"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "St. Jude Medical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "St. Jude Medical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}